Abstract:Although nanoparticles (NPs) have been demonstrated as promising tools for improving oral absorption of biotherapeutics, most of them still have very limited oral bioavailability. Lyso-endosomal degradation in epithelial cells is one of the important but often-neglected physiological barriers, limiting the transport of cargoes across the intestinal epithelium. We herein reported a solid lipid nanoparticle (SLN) platform with a unique feature of endosomal escape for oral protein drug delivery. The SLNs consisted of a solid-lipid shell, which contained an endosomal escape agent (GLFEAIEGFIENGWEGMIDGWYG, HA2), and an aqueous core that is loaded with insulin (INS HA2-O-SLNs). SLNs without and with the HA2 peptide in the aqueous core (INS SLNs and INS HA2-W-SLNs, respectively) were used as the control groups. Our study showed that INS HA2-O-SLNs effectively facilitated the escape of the loaded insulin from the acidic endosomes, which preserved the biological activity of insulin to a greater extent during the intracellular transport. The spatial location of the HA2 peptide was demonstrated to determine the endosomal escape efficiency. As demonstrated in the intracellular trafficking of SLNs, INS HA2-O-SLNs displayed much less distribution in late endosomes and lysosomes. Meanwhile, insulin in INS HA2-O-SLNs exhibited the highest transepithelial permeation efficiency, with 2.19 and 1.72 folds higher accumulated amount in the basolateral side as compared to that in INS SLNs and INS HA2-W-SLNs. In addition, insulin from INS HA2-O-SLNs exhibited the highest insulin permeation in various regions of small intestines. INS HA2-O-SLNs generated an excellent hypoglycemic response following oral administration in diabetic rats. Thus, such functional SLNs demonstrated a great potency for oral delivery of peptide/protein drugs.

Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin.

Experiment on the feasibility of using modified gelatin nanoparticles as insulin pulmonary administration system for diabetes therapy

Investigation of Lectin-Modified Insulin Liposomes As Carriers for Oral Administration

Solid lipid nanoparticles modified with stearic acid-octaarginine for oral administration of insulin.

Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.

Wheat Germ Agglutinin Modifies Insulin Solid Lipid Nanoparticles

Novel Solid Lipid Nanoparticles As Carriers for Oral Administration of Insulin.

Novel Solid Lipid Nanoparticle with Endosomal Escape Function for Oral Delivery of Insulin.

Solid Lipid Nanoparticles for Pulmonary Delivery of Insulin

A Novel Ligand Conjugated Nanoparticles for Oral Insulin Delivery.

Preparation of chitosan-based multifunctional nanocarriers overcoming multiple barriers for oral delivery of insulin.

Studies on Insulin-Loaded Stearylamine Nanoparticles:Preparation and Physicochemical Properties

Solid Lipid Nanoparticles As Insulin Inhalation Carriers for Enhanced Pulmonary Delivery.

Biodegradable Solid Lipid Nanoparticle Flocculates For Pulmonary Delivery Of Insulin

[Study on Preparation and Oral Efficacy of Insulin-Loaded Poly(lactic-Co-glycolic Acid) Nanoparticles].

Transport Characteristics Of Wheat Germ Agglutinin-Modified Insulin-Liposomes And Solid Lipid Nanoparticles In A Perfused Rat Intestinal Model

Preparation of insulin peptides-loaded solid lipids nanoparticles and their physicochemical properties

HP55-coated Capsule Containing PLGA/RS Nanoparticles for Oral Delivery of Insulin.

Novel Preparation of PLGA/HP55 Nanoparticles for Oral Insulin Delivery

In Situ Rearranged Multifunctional Lipid Nanoparticles Via Synergistic Potentiation for Oral Insulin Delivery.

Enteric-coated capsules filled with mono-disperse micro-particles containing PLGA-lipid-PEG nanoparticles for oral delivery of insulin